Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2005
06/08/2005CN1625555A Quinazoline compounds
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1205212C Fluorescent compounds, its rpeparation and use in industrial water systems
06/08/2005CN1205211C Pleuromutilin derivatives as antimicrobials
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/07/2005US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903127 Sexual disorders
06/07/2005US6903117 Indole derivatives for the treatment of osteoporosis
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903113 Urea substituted imidazopyridines
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction
06/07/2005US6903097 Heterocycle carboxamides as antiviral agents
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903095 Phthalimido derivatives and a process for their preparation
06/07/2005US6903091 Kidney diseases; hypotensive agents; blood disorders
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/07/2005US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
06/07/2005CA2209598C Aryl and heteroaryl purine compounds
06/02/2005WO2005049735A2 A process for aqueous milling of quinacridone pigments
06/02/2005WO2005049613A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005WO2005049605A1 Antibacterial aminoquinazolidinedione derivatives
06/02/2005WO2005049602A1 Quinolone antibacterial agents
06/02/2005WO2005049601A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005049585A1 Macrocyclic lactams and pharmaceutical use thereof
06/02/2005WO2005049581A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005WO2005049565A1 N-sulfonyldicarboximide containing tethering compounds
06/02/2005WO2005049559A2 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3)
06/02/2005WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
06/02/2005WO2005048953A2 Amide derivatives as kinase modulators
06/02/2005WO2005048948A2 Urea derivatives as kinase modulators
06/02/2005WO2005048945A2 Hydroxylamine substituted imidazo ring compounds
06/02/2005WO2005048933A2 Oxime substituted imidazo ring compounds
06/02/2005WO2005048916A2 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
06/02/2005WO2005048710A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005WO2005037197A3 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
06/02/2005WO2005028480A3 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
06/02/2005WO2005028474A3 Pyrazoloquinoline derivatives as chk-1 inhibitors
06/02/2005WO2005028445A3 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
06/02/2005WO2005023806A3 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
06/02/2005WO2005016245A3 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
06/02/2005WO2004094372A3 Compounds useful as serine protease inhibitors
06/02/2005US20050119482 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
06/02/2005US20050119298 Enantiomer (-) of tenatoprazole and the therapeutic use thereof
06/02/2005US20050119295 Fused heterocyclic compounds
06/02/2005US20050119294 Preparation of 1H-imidazo [4,5-c] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates
06/02/2005US20050119273 Small molecule toll-like receptor (TLR) antagonists
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119260 5-(7-Chloro-1-methyl-1H-indol-3-ylmethyl)-3-methyl-imidazolidine-2,4-dione; neurodegenerative and necrotic cell disease; non-apoptotic/caspase-independent cell death mechanisms; ischemia, stroke, cardiac infarction, infection and sepsis
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119231 Quinolone antibiotics such as 3-Amino-1-cyclopropyl-6-fluoro-7-(3-hydroxymethyl-pyrrolidin-1-yl)-8-methoxy-1H-quinazoline-2,4-dione, used for treating gramnegative or grampositive bacterial infection in mammals
06/02/2005US20050118454 organic light emitters elements comprising substrates laminated with electrodes, having brightness and durability; multilayers
06/02/2005US20050116627 Electrochromic salts, solutions, and devices
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005CA2546817A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005CA2546339A1 Antibacterial aminoquinazolidinedione derivatives
06/02/2005CA2546028A1 Novel compounds
06/02/2005CA2545825A1 Hydroxylamine substituted imidazo ring compounds
06/02/2005CA2545774A1 Oxime substituted imidazo ring compounds
06/02/2005CA2545725A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005CA2545711A1 Urea derivatives as kinase modulators
06/02/2005CA2545710A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005CA2545261A1 Piperidine-substituted indoles- or heteroderivatives thereof
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005CA2544751A1 Macrocyclic lactams and pharmaceutical use thereof
06/01/2005EP1535922A1 Pyrrolopyridine derivative and use thereof
06/01/2005EP1535630A1 Preventive for the onset of diabetes
06/01/2005EP1534716A1 Heterobicyclic pyrazole derivatives as kinase inhibitors
06/01/2005EP1534707A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
06/01/2005EP1534680A1 Prenylation inhibitors and methods of their synthesis and use
06/01/2005EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
06/01/2005EP1385847B1 Pyrazolo[1,5-a]pyridine derivatives
06/01/2005EP1335730B1 Use of pde5 inhibitors for the treatment of premature ejaculation
06/01/2005EP1219626B1 Compounds for fluorescence labeling
06/01/2005EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
06/01/2005CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
05/2005
05/31/2005US6900324 Reacting aminopyridine with 3-halo-butanone in cyclohexanone
05/31/2005US6900323 The present invention is directed to a series of chemical entitites that express HIV-1 inhibitory activities.
05/31/2005US6900316 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
05/31/2005US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
05/31/2005US6900224 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology.
05/31/2005US6900223 Dihydrodipyrazolopyridinone inhibitors of B7-1
05/31/2005US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
05/31/2005US6900217 Substituted 6,5-hetero-bicyclic derivatives
05/31/2005US6900206 For therapy of HIV (human immunodeficiency virus-1) infectio and AIDS (acquired immunodeficiency syndrome)
05/31/2005US6900205 Antidiabetic agents
05/31/2005US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/26/2005WO2005047286A1 Heterocyclic spiro compound
05/26/2005WO2005047285A1 Substituted naphthyridinone derivatives
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 646